This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Tretinoin (all-trans retinoic acid)
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict OPTIONAL-ADD HIGH
Massive replicated literature for acne and photoaging (gold-standard topical retinoid since 1971); but tretinoin is a documented trigger and aggravator of perioral/periorificial dermatitis — this user's primary current skin complaint. The right move is "zero-therapy" (stop topicals, eliminate triggers, possibly tetracycline-class oral antibiotic) for the POD first; add tretinoin later once skin is stable, if acne/aging-prevention is a goal. Verdict would upgrade to OPTIONAL-ADD or STRONG-CANDIDATE the moment POD is resolved and a user in this archetype wants to start a long-horizon photoaging-prevention layer.
▸ Decision matrix by user profile Per-archetype
| Archetype | Verdict | Rationale |
|---|---|---|
★20-30, brain-priority, high cognitive workload, ACTIVE perioral dermatitis (this-archetype RIGHT NOW) | — | - SKIP-FOR-NOW. Tretinoin is contraindicated for active POD. Pursue zero-therapy first, escalate to oral tetracycline if needed, NOT topical retinoid. |
★20-30, brain-priority, no active inflammatory skin condition, photoaging-prevention goal (this-archetype FUTURE STATE post-POD) | — | - OPTIONAL-ADD. Start 0.025% 2 nights/week, slow titration, avoid perioral zone, AM SPF mandatory. ~$25/mo. Long-horizon insurance against photoaging. |
20-30, ACNE primary complaint (acne-archetype) | — | - STRONG-CANDIDATE / PRIMARY-PICK for topical retinoid. 0.025-0.05% nightly with slow titration; combine with BPO (timing-separated) or adapalene (BPO-stable). Add oral doxycycline if moderate-severe inflammatory. |
30-50, executive maintenance | — | - STRONG-CANDIDATE for photoaging prevention. 0.025-0.05% 3-5 nights/week indefinitely. Pair with AM vitamin C + SPF. |
50+, established photoaging | — | - STRONG-CANDIDATE / PRIMARY-PICK. Best demographic for visible benefit. 0.05-0.1% nightly long-term; pair with vitamin C, niacinamide, SPF. |
Anxiety-prone | — | - Neutral. Topical, no systemic effect on anxiety axis. |
High athletic load, tested status (WADA-relevant) | — | - SAFE. Not on WADA Prohibited List. Topical retinoid is allowable for any tested athlete. |
Sleep-disordered | — | - Neutral. No sleep-axis effect. |
Recovery-focused (post-injury, post-illness) | — | - Neutral / mild positive for surface healing of cuts/scrapes (post-spar abrasions on combat-sport context-context); pair with petrolatum / GHK-Cu for primary wound healing. Tretinoin's role is more in scar minimization once acute healing is done. |
Strength / anabolic-focused | — | - Neutral. Topical, no anabolic relevance. |
Pregnancy or planning conception | — | - CONTRAINDICATED. Discontinue 1 month before planned conception. |
Skin of color (Fitzpatrick IV-VI) | — | - STRONG-CANDIDATE for photoaging, melasma, PIH. Use *more conservative* titration (start 0.025% 1×/week) — over-irritation in skin of color → post-inflammatory hyperpigmentation. Hydroquinone / niacinamide combinations often paired. |
Rosacea / perioral dermatitis / sensitive eczema-prone skin | — | - SKIP (during active disease). Treat underlying condition first; consider gentler alternatives (azelaic acid, niacinamide, adapalene as a milder retinoid option) once skin is stable. |
- ★20-30, brain-priority, high cognitive workload, ACTIVE perioral dermatitis (this-archetype RIGHT NOW)—
- SKIP-FOR-NOW. Tretinoin is contraindicated for active POD. Pursue zero-therapy first, escalate to oral tetracycline if needed, NOT topical retinoid.
- ★20-30, brain-priority, no active inflammatory skin condition, photoaging-prevention goal (this-archetype FUTURE STATE post-POD)—
- OPTIONAL-ADD. Start 0.025% 2 nights/week, slow titration, avoid perioral zone, AM SPF mandatory. ~$25/mo. Long-horizon insurance against photoaging.
- 20-30, ACNE primary complaint (acne-archetype)—
- STRONG-CANDIDATE / PRIMARY-PICK for topical retinoid. 0.025-0.05% nightly with slow titration; combine with BPO (timing-separated) or adapalene (BPO-stable). Add oral doxycycline if moderate-severe inflammatory.
- 30-50, executive maintenance—
- STRONG-CANDIDATE for photoaging prevention. 0.025-0.05% 3-5 nights/week indefinitely. Pair with AM vitamin C + SPF.
- 50+, established photoaging—
- STRONG-CANDIDATE / PRIMARY-PICK. Best demographic for visible benefit. 0.05-0.1% nightly long-term; pair with vitamin C, niacinamide, SPF.
- Anxiety-prone—
- Neutral. Topical, no systemic effect on anxiety axis.
- High athletic load, tested status (WADA-relevant)—
- SAFE. Not on WADA Prohibited List. Topical retinoid is allowable for any tested athlete.
- Sleep-disordered—
- Neutral. No sleep-axis effect.
- Recovery-focused (post-injury, post-illness)—
- Neutral / mild positive for surface healing of cuts/scrapes (post-spar abrasions on combat-sport context-context); pair with petrolatum / GHK-Cu for primary wound healing. Tretinoin's role is more in scar minimization once acute healing is done.
- Strength / anabolic-focused—
- Neutral. Topical, no anabolic relevance.
- Pregnancy or planning conception—
- CONTRAINDICATED. Discontinue 1 month before planned conception.
- Skin of color (Fitzpatrick IV-VI)—
- STRONG-CANDIDATE for photoaging, melasma, PIH. Use *more conservative* titration (start 0.025% 1×/week) — over-irritation in skin of color → post-inflammatory hyperpigmentation. Hydroquinone / niacinamide combinations often paired.
- Rosacea / perioral dermatitis / sensitive eczema-prone skin—
- SKIP (during active disease). Treat underlying condition first; consider gentler alternatives (azelaic acid, niacinamide, adapalene as a milder retinoid option) once skin is stable.
▸ Subjective experience (deep)
First 4-8 weeks ("retinization" / "retinoid uglies" phase):
- Mild-to-moderate erythema, scaling, peeling, dryness — peaks week 2-4, gradually resolves
- Initial purge (week 2-6) — pre-existing microcomedones surface as visible acne; this is mechanism-correct (the medication is doing its job by accelerating turnover) but cosmetically frustrating
- Photosensitivity — skin is more vulnerable to UV damage; AM SPF 30+ mandatory
- Stinging on application — common; reduces with tolerance
- Some users develop a hyperpigmented or red ring around the nose/mouth in the first month (overlap with POD-trigger phenomenon — pause if this appears)
8-16 weeks (tolerance + early benefit):
- Irritation diminishes substantially
- Texture begins to smooth; pores appear smaller
- Acne lesion count drops
- Tone evens; PIH from old acne fades
3-12 months (full benefit):
- Visible reduction in fine wrinkles (especially periorbital, perioral)
- Brighter, more uniform tone
- Sustained acne control (continued use)
- Increased epidermal "glow"
The "tretinoin face" failure mode (overdone protocol): Aggressive use (nightly from day 1, 0.1% concentration, no moisturizer buffer) → chronic irritation, paradoxical worsening of acne, barrier compromise, increased photoaging from inflammation, possible POD precipitation. Slow titration is essential.
For relevant-to-archetype POD context: If applied during active perioral dermatitis: high probability of flaring the dermatitis in the first 1-2 weeks. Lesions become more red, scaly, painful. This is the wrong response — pause and pursue zero-therapy.
▸ Tolerance + cycling deep dive
- Tolerance buildup: Yes, in the positive sense — irritation decreases over weeks 4-12. Therapeutic effect does NOT diminish; sustained benefit on continuous use.
- Cycling: Not generally needed. Some practitioners suggest brief breaks (1-2 weeks/year) if barrier shows signs of compromise. Not evidence-based as a requirement.
- Reset protocol: If overdone (chronic irritation), pause × 2-4 weeks, restore barrier with bland emollients (Cetaphil, Vanicream, CeraVe), then restart at lower concentration / lower frequency.
▸ Stacking deep dive
Synergistic with
- niacinamide (topical 4-10%): reduces tretinoin irritation, restores barrier, complementary anti-pigmentation. Apply niacinamide AM, tretinoin PM (or layer with niacinamide first if combining).
- vitamin C (L-ascorbic acid 10-20%, topical AM): synergistic anti-photoaging — vitamin C drives collagen crosslinking (lysyl oxidase cofactor), tretinoin drives collagen transcription. Apply vitamin C AM, tretinoin PM (separate by ~12 hours; pH conflict if simultaneous — vitamin C ~3.5, tretinoin ~5-6).
- ghk-cu (topical): complementary mechanism (signal-side collagen + barrier repair vs tretinoin's transcription effects). Apply GHK-Cu AM, tretinoin PM (timing-separated). The 2017 chart review showing 3.2× higher irritation with same-application stacking supports timing separation, not avoidance.
- hyaluronic acid (topical): simple humectant layer; reduces tretinoin dryness without efficacy loss.
- azelaic acid 15-20% (topical): anti-inflammatory + anti-comedonal + brightening; gentler partner with tretinoin; can alternate nights.
- clindamycin (topical) or BPO (timing-separated for older formulations): acne combination protocols.
- oral doxycycline 100 mg/d × 6-12 weeks: for moderate-severe inflammatory acne, paired with topical tretinoin.
Avoid stacking with (or use with caution)
- Benzoyl peroxide (older tretinoin formulations, same-application): BPO oxidizes/deactivates tretinoin → loss of efficacy. Solution: BPO in AM, tretinoin in PM, OR use tretinoin microsphere (Retin-A Micro), which is BPO-stable, OR use adapalene (BPO-stable in any formulation).
- Salicylic acid, glycolic acid, lactic acid, other AHA/BHA exfoliants — same application: compound irritation. Use on alternate nights or separate AM/PM.
- Hydroquinone — long-term: fine in Kligman's triple-combination protocol (8-12 weeks). Avoid chronic indefinite combination; risk of ochronosis with prolonged hydroquinone.
- Waxing, threading, depilatory creams in the treated area: pause tretinoin 5-7 days before; risk of skin tearing.
- IPL, laser resurfacing, chemical peels, microneedling: pause tretinoin 5-7 days before and after.
- Active POD, rosacea, eczema: treat underlying condition first; tretinoin can flare these.
Neutral / safe co-administration
- All the canonical stack oral supplements (no interaction with topical retinoid)
- Modafinil, bromantane, Adamax/Semax, all nootropics
- BPC-157, TB-500, Cerebrolysin (different routes; no interaction)
- Standard moisturizers (Cetaphil, Vanicream, CeraVe, etc.) — recommended adjunct
- AM sunscreen (mandatory)
- Most other oral medications
▸ Drug interactions deep dive
- CYP enzymes: Topical tretinoin has minimal systemic absorption (~2%) at standard doses; no clinically significant CYP interactions. Oral isotretinoin (different drug) is CYP3A4 metabolized but is irrelevant here.
- Vitamin A oral supplements: avoid high-dose oral vitamin A (>10,000 IU/d retinol) when using oral retinoids; not relevant for topical tretinoin at clinical doses.
- Anti-acne combination drugs: BPO timing issue (above); clindamycin OK; doxycycline OK and synergistic.
- Hormonal contraceptives: No interaction (irrelevant for users in this archetype).
- Pregnancy: AVOID — see contraindications.
- Light-sensitizing drugs (tetracyclines, fluoroquinolones, thiazides): additive photosensitivity; AM SPF essential.
▸ Pharmacogenomics
- Limited / not clinically actionable. Individual variation in retinoid sensitivity exists but no pharmacogenomic test currently guides dosing.
- CYP26A1 / CYP26B1 (retinoic acid hydroxylases) — polymorphisms theoretically modulate ATRA metabolism but no clinical actionability.
- RAR receptor polymorphisms — academic interest; no dosing implication.
- For the user's 23andMe (June 2026): no specific tretinoin-relevant variants to pull beyond general inflammatory-skin-condition variants (e.g., filaggrin LoF for atopic dermatitis tendency).
▸ Sourcing deep dive
| Path | Vendor | Cost | Reliability | Notes |
|---|---|---|---|---|
| US Rx (recommended for tretinoin specifically) | Local pharmacy (CVS, Walgreens, Costco) with telehealth Rx (Hers, Curology, Apostrophe, Nurx) | $10-30/mo generic | High | Standard of care; insurance often covers acne indication. Curology / Apostrophe formulate custom (tretinoin + niacinamide + clindamycin etc.) for ~$25/mo. |
| US Rx generic (cheapest) | GoodRx pharmacy | $8-15 / 20 g tube | High | Generic Cipher-equivalent; multiple manufacturers; quality consistent |
| US Rx branded | Retin-A Micro, Renova, Atralin | $200-400/tube without insurance | High | Generic is bioequivalent for nearly all users; rarely worth branded |
| Compounded Rx | Strive Pharmacy, Defy Medical, telehealth peptide pharmacies | $40-80/mo | High | Custom formulations (tretinoin + niacinamide + GHK-Cu + estriol etc.) — convenient for stack-in-one-tube users |
| OTC alternative | Adapalene 0.1% (Differin) | $15-25 / 45 g tube | High | OTC since 2016; gentler than tretinoin; comparable efficacy at 0.1%; better starter for POD-prone or sensitive skin |
| OTC retinol (precursor) | The Ordinary, Paula's Choice, CeraVe | $10-30/bottle | Variable | ~10-20× less potent than tretinoin (must convert retinol → retinaldehyde → tretinoin in skin); useful for very sensitive skin or as gateway |
| Mexico / international | Pharmacy without Rx | varies | Variable | Tretinoin is OTC in Mexico and many countries; quality variable; not recommended over US generic Rx given low cost |
Cost math for users in this archetype (if/when he starts post-POD-resolution):
- Generic tretinoin 0.025% via GoodRx: $10/mo
- Or OTC Differin (adapalene 0.1%): ~$5-7/mo amortized over 6-month tube
- Plus moisturizer (Vanicream / CeraVe): $10/mo
- Plus AM sunscreen (mandatory anyway): $10-20/mo
- Total: $25-40/mo added to skin layer
▸ Biomarkers to track (deep)
Baseline (before starting)
- Photographs at consistent lighting (front, both sides, close-up of any target areas) — week 0
- Skin condition documentation — note any rosacea, POD, eczema, dyspigmentation, active acne lesion count
- Barrier integrity (subjective: dry/oily/normal; quantitative TEWL only if research-grade interest)
During use (weekly first 8 weeks; monthly thereafter)
- Weekly photographs (consistent lighting, ideally same time of day, no recent makeup)
- Track: irritation level (1-10), peeling, redness, any new lesions
- Watch for POD precipitation signs: red papules + scaling specifically around mouth/nose/eyes → STOP if observed
- Monthly: lesion count (if treating acne), subjective texture/tone
Post-cycle (if discontinued)
- Photo comparison at 4 and 12 weeks post-discontinuation
- Most photoaging benefit fades over 6-12 months without continued use; acne benefit fades within 4-8 weeks (microcomedones return)
For the user specifically (current state)
- DO NOT START tretinoin while POD is active.
- Track POD instead: weekly photographs of nose, lesion description (papules vs scales vs erythema), trigger log (toothpaste brand, moisturizers, sunscreens, climate, stress)
- If pursuing zero-therapy: photo + symptom log weekly × 4-8 weeks; if not resolved, dermatologist referral for tetracycline-class oral antibiotic
- POD resolution criteria: clear skin × 4 weeks → only THEN consider adding tretinoin (0.025%, 2 nights/week, AVOIDING perioral zone)
▸ Controversies / open debates Live debate
Tretinoin vs adapalene first-line — settled-ish. Adapalene 0.1% has comparable efficacy with less irritation in head-to-head RCTs. Many dermatologists now default to adapalene as first-line, especially OTC. Tretinoin retains slight edge for severe acne and for photoaging RCT depth. For this-archetype POD-prone user: adapalene is the safer choice if/when starting a retinoid.
Tretinoin and rosacea/POD — not actually controversial. Universal dermatology consensus: avoid retinoids in active rosacea/POD. The minority view that "you can push through irritation and tolerize" is wrong for rosacea-spectrum conditions — those are inflammatory diseases that retinoid-induced inflammation aggravates, not transient barrier-tolerance issues that resolve with time.
Tretinoin "thins skin" — myth. Old myth from 1980s misinterpretation. Tretinoin reduces stratum corneum thickness (slightly) but increases epidermal viable layer thickness AND dermal collagen density. Net effect: thicker, more youthful skin. This myth occasionally surfaces in lay discussions.
Sunscreen requirement — sometimes underplayed. A subset of users skip AM sunscreen because they apply tretinoin only at night and "wash it off in the morning." Photosensitivity is a mechanism-driven skin state (faster turnover → less protective stratum corneum) that persists regardless of when tretinoin was applied. AM SPF 30+ is mandatory year-round on tretinoin.
Pregnancy risk — relative vs absolute. FDA labels topical tretinoin as Pregnancy Category C (animal data shows risk; human data limited). Some dermatologists treat it as relatively safe due to ~2% systemic absorption; others (and the FDA) treat it as absolutely contraindicated. Default conservative: discontinue if planning pregnancy. Not relevant for the user currently.
Combination with GHK-Cu — timing-separated, not avoided. Some sources flag these as incompatible; the actual issue is same-application irritation. Timing-separated (GHK-Cu AM, tretinoin PM, or alternate nights) is well-tolerated and mechanistically synergistic.
▸ Verdict change log
- 2026-05-06 — Initial verdict (this file):
- For the user's CURRENT nose perioral dermatitis: SKIP-FOR-NOW (HIGH confidence — universal dermatology consensus that retinoids precipitate/aggravate POD; standard of care is zero-therapy + tetracycline if needed, NOT retinoid).
- For the user's tinea cruris (groin): NOT INDICATED — stay on clotrimazole 1% (azole antifungal); tretinoin is wrong drug class for fungal infection.
- For the user's future state (POD resolved + acne or photoaging-prevention goal): OPTIONAL-ADD (HIGH confidence — gold-standard topical retinoid; well-replicated A-tier evidence). Start 0.025% 2 nights/week; avoid perioral zone; AM SPF mandatory; OR consider OTC adapalene 0.1% (Differin) as gentler alternative.
▸ Open questions / gaps Open
- Confirmation of the user's nose dermatitis Dx: "Perioral dermatitis" is a working clinical hypothesis. Could also be seborrheic dermatitis (different management — antifungal shampoo, low-dose ketoconazole cream), rosacea (azelaic acid, ivermectin, low-dose doxycycline), demodex folliculitis (similar to rosacea), contact dermatitis (eliminate contactant), or psoriasis (very different). A dermatologist visit before locking treatment plan is high-value. Tretinoin verdict is "skip" for all of these inflammatory presentations regardless of which it actually is.
- Whether to use adapalene vs tretinoin once skin is stable — adapalene's safety margin in POD-prone users is better; tretinoin's RCT depth is bigger. Default to adapalene for users in this archetype if/when starting a retinoid.
- Optimal "buffer zone" around nose/mouth for POD-prone users — clinical guidance is "avoid perioral zone" but the exact safe distance isn't well-defined. Conservative: stay 2+ cm from nostrils and lip line.
- Long-term (5+ year continuous use) safety in young adults — well-established benefit profile, no emerging concerns; likely fine but the original Kligman cohorts were middle-aged-and-older.
▸ Cross-references
Related compound files in this wiki:
- isotretinoin.md — oral retinoid for severe nodulocystic acne (different drug; systemic; teratogen; reserved for refractory cases)
- ghk-cu.md — complementary copper-peptide topical; timing-separated AM/PM stack; barrier-repair partner; safer choice for users in this archetype's POD context
- kpv.md — anti-inflammatory tripeptide; potential POD-relevant alternative
- niacinamide.md — barrier-restoration partner; reduces tretinoin irritation
- clotrimazole.md — for users in this archetype's tinea cruris (different problem; azole antifungal; not retinoid territory)
References
Kligman AM et al. *Topical tretinoin for photoaged skin.* J Am Acad Dermatol 1986
original photoaging RCT
View StudyWeinstein GD et al. *Topical tretinoin for treatment of photodamaged skin: a multicenter study.* Arch Dermatol 1991
confirmatory multicenter trial
View StudyCochrane review: topical retinoids for acne vulgaris
meta-analysis of retinoid efficacy
View SourceAmerican Academy of Dermatology — Acne Guidelines 2024
first-line topical retinoid recommendation
View SourceTolaymat L, Hall MR. *Perioral Dermatitis.* StatPearls 2023
POD pathogenesis + management; lists topical retinoids as triggers
View SourceKang S et al. *Mechanism of retinol-induced epidermal hyperplasia.* J Invest Dermatol 1995
mechanism of retinoid epidermal effects
View SourceFDA Renova prescribing information
1995 FDA approval for photodamage
View SourceKligman's triple-combination cream (Tri-Luma) prescribing info
melasma combination protocol
View SourceCurology / Apostrophe / Hers compounded tretinoin services
telehealth Rx pathway
View SourceHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.